Vyasa Enhances Cancer Screenings with NVIDIA-Accelerated AI
One in eight women will develop breast cancer in their lifetime.
In a recent blog post, I discussed the decline in preventative cancer screenings as a result of the COVID-19 pandemic and how this is impacting an already strained healthcare system. Fortunately, advancements in deep learning and image analytics combined with powerful compute infrastructure are solving this challenge head on.
At Vyasa, we’ve developed a novel approach to improve how healthcare professionals can analyze patient populations. Our deep learning data fabric, Layar, unifies disparate data sources while deep learning models tag and catalog structured and unstructured content. As a result, all information within a healthcare system can become easily searchable and accessible within a single, secure and flexible platform.
See how Vyasa, in collaboration with NVIDIA and iCAD, can improve the breast cancer screening process with AI:
Adopting powerful deep learning capabilities no longer needs to be a headache. The NVIDIA AI Enterprise software suite streamlines the often significant complexities of integration with existing infrastructure and new applications that would usually take years to complete. Vyasa, in collaboration with NVIDIA, offers solutions that can be easily deployed, managed and scaled within a healthcare system.
Robin Braun is the Chief Commercial Officer for Vyasa, driving GTM and Sales. Robin has worked in strategic positions across the technology industry for 25+ years including customer care, GTM, business modernization, quality and partner engagement. Previously, she was the Global Storage CIO for Healthcare at Dell Technologies where she engaged globally in discussing the role of data and AI in healthcare.